Mercier, M.; Lescoat, A.; Pierre-Jean, M.; Dumontet, E.; Le Lous, M.; Belhomme, N.
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria. J. Clin. Med. 2024, 13, 7698.
https://doi.org/10.3390/jcm13247698
AMA Style
Mercier M, Lescoat A, Pierre-Jean M, Dumontet E, Le Lous M, Belhomme N.
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria. Journal of Clinical Medicine. 2024; 13(24):7698.
https://doi.org/10.3390/jcm13247698
Chicago/Turabian Style
Mercier, Marion, Alain Lescoat, Morgane Pierre-Jean, Erwan Dumontet, Maela Le Lous, and Nicolas Belhomme.
2024. "Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria" Journal of Clinical Medicine 13, no. 24: 7698.
https://doi.org/10.3390/jcm13247698
APA Style
Mercier, M., Lescoat, A., Pierre-Jean, M., Dumontet, E., Le Lous, M., & Belhomme, N.
(2024). Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria. Journal of Clinical Medicine, 13(24), 7698.
https://doi.org/10.3390/jcm13247698